abstract |
Formula I: Wherein R1, R2 and R3 are as defined herein. Disclosed are compounds having and methods of making and using the same, including use as inhibitors of BMP1, TLL1 and / or TLL2, and in the treatment of diseases associated with BMP1, TLL1 and / or TLL2 activity. |